Estimates Revisions Beam Therapeutics Inc.
Stocks
BEAM
US07373V1052
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 25.18 USD | -6.17% |
|
-13.25% | -9.18% |
| 09-09 | Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01:00 PM | |
| 09-08 | Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints | DJ |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BEAM Stock
- Consensus Beam Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
